← Open Payments lookup

RUDO MADONDO-GWITIRA: Open Payments

NPI 1396351474 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,786 in 87 payments from 21 companies in 2025. Trend: 2023 $309 · 2024 $1,422 · 2025 $1,786

Food & beverage: $1,696Education: $90
CompanyPaymentsAmount
Novo Nordisk Inc12$226
Astellas Pharma US Inc6$180
GlaxoSmithKline, LLC.8$169
AstraZeneca Pharmaceuticals LP8$168
PFIZER INC.9$159
Lilly USA, LLC9$154
Eisai Inc.5$152
Bayer Healthcare Pharmaceuticals Inc.7$137
Avvisto Therapeutics, LLC3$58
Boehringer Ingelheim Pharmaceuticals, Inc.3$48

Products named: Leqembi, Kerendia, TRELEGY ELLIPTA, MOUNJARO, AIRSUPRA, Veozah, JARDIANCE, Ozempic.

Industry payments across TX — which companies pay providers there.